Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier inSDHD-linked paragangliomas:SLC22A18andCDKN1Care candidate tumour modifiers-Reference-Cited by-同舟云学术

Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier inSDHD-linked paragangliomas:SLC22A18andCDKN1Care candidate tumour modifiers

Published:2016-07-08 Issue:17 Volume:25 Page:3715-3728
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:Hum. Mol. Genet.

Author:

Hoekstra Attje S,Addie Ruben D.,Ras Cor,Seifar Reza M.,Ruivenkamp Claudia A.,Briaire-de Bruijn Inge H.,Hes Frederik J.,Jansen Jeroen C.,Corssmit Eleonora P.M.,Corver Willem E.,Morreau Hans,Bovée Judith V.M.G.,Bayley Jean-Pierre,Devilee Peter

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Reference54 articles.

1. Phaeochromocytoma

2. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal

3. SDHA is a tumor suppressor gene causing paraganglioma

4. Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

5. Mutations in SDHC cause autosomal dominant paraganglioma, type 3

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolutionary impact of childhood cancer on the human gene pool;Nature Communications;2024-02-29

2. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling;Holland‐Frei Cancer Medicine;2022-10-21

3. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours;Endocrine-Related Cancer;2022-10-01

4. Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort;BMC Medicine;2022-06-07

5. Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma;Frontiers in Pharmacology;2020-09-25